{ "schemaVersion": "deck-intelligence.v1", "id": "019de074-2763-7087-8fbd-df19b6e58266", "slug": "1ca51573de190fbfcf19415b61000ddd", "title": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "subtitle": "AstraZeneca ยท 2023-01", "author": "AstraZeneca", "date": "2023-01-01 00:00:00", "pageCount": 18, "kind": "conference-presentation", "orientation": "landscape", "aspectRatio": 1.7777778, "document": { "id": "019de074-2763-7087-8fbd-df19b6e58266", "slug": "1ca51573de190fbfcf19415b61000ddd", "title": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "rawTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "authorDisplay": "AstraZeneca", "kind": { "slug": "conference-presentation", "label": "Conference presentation" }, "sourceType": { "slug": "investor_relations", "label": "Investor relations" }, "fileName": "2023-01__astrazeneca__investor-conf__1ca51573.pdf", "sourceUrl": "https://www.slidebook.io/company/astrazeneca/presentation/1ca51573de190fbfcf19415b61000ddd/", "sourceDate": "2023-01-09 00:00:00", "presentationDate": "2023-01-01 00:00:00", "ingestedAt": "2026-04-30 22:13:21.993159+00", "status": "ready", "pageCount": 18, "orientation": "landscape", "aspectRatio": 1.7777778, "targetCompany": null, "targetTicker": null, "metadata": { "corpus": "slidebook", "industry": "drug-manufacturers-general", "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-01__astrazeneca__investor-conf__1ca51573", "image_width": 1920, "image_format": "jpg", "deck_type_raw": "Investor Conference Presentation Deck", "deck_type_slug": null, "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/" } }, "coverage": { "pageCount": 18, "pagesIndexed": 18, "pagesWithImages": 18, "pagesWithMetadata": 18, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 107, "chartCount": 7, "metricSlides": 0, "toolMatches": 10, "documentToolMatches": 0, "frameworkMatches": 4, "arcMatches": 1, "beatMatches": 7, "loopMatches": 2, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "evidence": "The presentation follows a logical structure starting with why (science-led, patient-centered), what (key messages, financials, pipeline), and how (execution, growth strategy).", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.202332+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 1, "name": "Why", "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 4, "name": "Key Messages", "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 5, "name": "KPI Overview", "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 10, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 9, "name": "Thesis Headline", "beatId": "d24e6f2d-ed7f-45f3-8426-4526ac01fda7", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 13, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 12, "name": "Roadmap", "beatId": "c2902914-1df6-44f4-9a90-1f972465d662", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory.", "position": 5, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 15, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 15, "name": "Closing Ask", "beatId": "d25d54ad-e329-4cda-a857-30b5fce1a06b", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The presentation concludes with a call for Q&A, engaging investors directly.", "position": 6, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null, "categoryName": "Vision", "categorySlug": "vision" }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 10, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "f577db34-3711-4966-ab1d-a155e7015552", "evidence": "The presentation highlights the strategic rationale for the acquisition at this time.", "position": 1, "objective": "To justify the timing of the acquisition of CinCor Pharma", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:29:13.514063+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "02c4f2c0-011b-425f-a551-b474fa7ede68", "evidence": "type: cover", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:55.920615+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "2756606b-d131-4e65-b4cf-7bcfb33ff644", "evidence": "type: executive_summary", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:56.052101+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "ff9e8842-dfe1-4e32-9431-53c15bc1cb07", "evidence": "list/bullet: Environmental protection, Access to healthcare, Ethics and transparency", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.096427+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "71ac725e-9090-45c9-99ff-05732e5084fb", "evidence": "list/bullet: We follow the science; We put patients first; We play to win; We do the right thing; We are entrepreneurial", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.182648+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "351bfb55-10a6-410d-831c-09608c7c5e9d", "evidence": "list/bullet: S&P Global and Moody's credit ratings", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.312563+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a877eebb-4f9c-42e1-b4d4-6de563c23de5", "evidence": "list/bullet: Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.399364+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "3aa95fc4-12a6-4507-aed4-2c529320ade3", "evidence": "table/data: Matrix comparing 9M 2022 performance and 2023 focus across three therapy areas.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.486165+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "148e3c75-ec2b-4cf6-8ba9-fc0b7645c2a8", "evidence": "type: executive_summary", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:56.618016+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "1928505f-be27-4654-b57a-8fb832759f37", "evidence": "list/bullet: Regulatory approvals in major markets, including:", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.704313+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "aa882962-b243-4dca-b0bb-631b64cadb39", "evidence": "chart/bar-vertical: Growth from robust portfolio and an innovative pipeline", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:17:38.095808+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [ { "matchId": "9e7a276d-2dca-466d-b78d-cfa8c2e13419", "evidence": "The slide explicitly categorizes capital into four distinct strategic buckets (ratings, R&D, BD, dividends).", "framework": null, "confidence": 0.95, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "capital-allocation-framework" }, { "matchId": "588de2af-e79a-42f1-862b-7e5563375980", "evidence": "Explicitly stated as the strategic framework for R&D investment.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "Growth Through Innovation" }, { "matchId": "cb2c11da-cabc-4275-9887-9fc9081c2dd8", "evidence": "Chronological presentation of H1 and H2 2023 events", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "frameworkName": "timeline" }, { "matchId": "fdc5cc13-0742-4b7e-b56b-cd92b28c51ca", "evidence": "Numbered list of strategic pillars", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "frameworkName": "list-presentation" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/XNWxPTiCcjBE3i_6Vrlg-JQkot1voTZDxN5U6LXMjaI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLmpwZw", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 39, "componentCount": 5, "textChars": 195, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:11.971+00", "seconds": 3.021, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/1", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-1", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 1, "w": 0.48, "x": 0.52, "y": 0 }, "kind": "image", "text": "Stylized human silhouette with internal biological imagery", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:11.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "049bc620-e47f-4f62-b939-d668a6b2fc28", "parentComponentId": null }, { "bbox": { "h": 0.17, "w": 0.23, "x": 0.033, "y": 0.088 }, "kind": "image", "text": "AstraZeneca logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:11.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5bfe1101-5d75-4b4e-9f0a-d1ed1d8139a8", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.25, "x": 0.033, "y": 0.64 }, "kind": "paragraph", "text": "Aradhana Sarin, Executive Director and Chief Financial Officer", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:11.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c7c4051-6ce9-493c-83bb-72e5287d0bfd", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.1, "x": 0.033, "y": 0.87 }, "kind": "paragraph", "text": "9 January 2023", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:11.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5124564-bbff-442b-8a94-cd80b03ec57c", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.25, "x": 0.033, "y": 0.295 }, "kind": "title", "text": "J.P. Morgan 41st Annual Healthcare Conference", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:11.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "973727d5-a53d-437e-ab53-45930e8b8c59", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "02c4f2c0-011b-425f-a551-b474fa7ede68", "evidence": "type: cover", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:55.920615+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 1, "name": "Why", "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/yF6Ee7RB4i4A1URq1QcR6luTCV8sX7LmJeNIY33uzv0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLmpwZw", "imagePathAlt": "https://imgproxy.kitesheet.com/D1INx3bSZDJInhAYRY5NRRAYOXnYgpfh3THIqh0jVWI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLnBuZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/zsh_HFYyAlN16H1eo8QmJrdXAyPm61txi8Ay8BN5apw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xY2E1MTU3M2RlMTkwZmJmY2YxOTQxNWI2MTAwMGRkZC9wMDAxLnBuZw" }, { "page": 2, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "sparse", "densityScore": 18, "componentCount": 2, "textChars": 248, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:10.927+00", "seconds": 1.823, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/2", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-2", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.9, "x": 0.05, "y": 0.23 }, "kind": "disclaimer", "text": "AstraZeneca (hereafter 'the Group') provides the following cautionary statement: this document contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group...", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:10.927+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c471ba5d-8726-4e44-aa43-22c303f6197e", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.05, "y": 0.06 }, "kind": "title", "text": "Forward-looking statements", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:10.927+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "664dbe82-87ed-4259-8013-7f6cc235d926", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 1, "name": "Why", "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide uses a four-column layout to summarize key corporate metrics and strategic focus areas.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 81, "componentCount": 10, "textChars": 447, "nDataPoints": 8, "notes": "The slide uses a four-column layout to summarize key corporate metrics and strategic focus areas.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:12.295+00", "seconds": 3.135, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/3", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-3", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.07, "w": 0.82, "x": 0.03, "y": 0.915 }, "kind": "disclaimer", "text": "1. Ambition Zero Carbon... 2. 50m people cumulatively reached...", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1ae468ce-1fef-432c-9608-2ce0f7b9536f", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.25, "x": 0.69, "y": 0.56 }, "kind": "list", "text": "Environmental protection, Access to healthcare, Ethics and transparency", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "71295b37-0574-4068-b90b-ec598851cc82", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.18, "x": 0.28, "y": 0.56 }, "kind": "list", "text": "Oncology, BioPharmaceuticals (CVRM, R&I, V&I), Rare Disease", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9e27e197-d1f8-458c-9e6a-7ddb68c0f551", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.07, "y": 0.65 }, "kind": "metric", "text": ">35 major regulatory registrations events in 2022", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0c01badf-ecc4-4aa1-92f0-897fb11bbd5a", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.07, "y": 0.75 }, "kind": "metric", "text": "13 new molecular entities in pipeline", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5c3fde68-1708-4ce7-9191-27bb251c0c7c", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.07, "y": 0.56 }, "kind": "metric", "text": "179 projects in our pipeline", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "88f6e277-623a-4d26-8071-06dcdf9de92d", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.51, "y": 0.7 }, "kind": "metric", "text": "$5.28 Core EPS in 9M 2022", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d155adaa-0263-4eca-9c7e-74d095d7b4fc", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.51, "y": 0.56 }, "kind": "metric", "text": "$33.1bn Total Revenue in 9M 2022", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f5b4f61c-760b-4f9a-9e59-e2a651629ad6", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.59, "x": 0.03, "y": 0.14 }, "kind": "title", "text": "Developing innovative medicines for millions globally", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "affa91f1-844d-49ff-9584-ba29d8ecf460", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.43, "x": 0.03, "y": 0.07 }, "kind": "title", "text": "Science-led, patient-centered", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.295+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1a5f97ec-44ee-4196-b266-f39ba203fd06", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "2756606b-d131-4e65-b4cf-7bcfb33ff644", "evidence": "type: executive_summary", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:56.052101+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "ff9e8842-dfe1-4e32-9431-53c15bc1cb07", "evidence": "list/bullet: Environmental protection, Access to healthcare, Ethics and transparency", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.096427+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 1, "name": "Why", "beatId": "c522e53a-9637-425f-9c8a-3dd0c2f9d5e6", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered).", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 4, "type": "setup", "title": "Slide 4 of a presentation, likely AstraZeneca.", "function": "summarize", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 7, "textChars": 381, "nDataPoints": 2, "notes": "Slide 4 of a presentation, likely AstraZeneca.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:12.847+00", "seconds": 3.503, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/4", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-4", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.25, "x": 0.68, "y": 0.15 }, "kind": "image", "text": "Four images showing clinical trials, vaccine development, testing, and patient care.", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "789eb5d3-e82a-47aa-9471-423296f952ea", "parentComponentId": null }, { "bbox": { "h": 0.5, "w": 0.25, "x": 0.32, "y": 0.15 }, "kind": "list", "text": "We follow the science; We put patients first; We play to win; We do the right thing; We are entrepreneurial", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "21b5bb01-9c75-474a-ada0-6f3cfa1f06bb", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.32, "y": 0.75 }, "kind": "metric", "text": "83,000 employees worldwide", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37f1f5d3-1a87-4361-becc-db2491525525", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.15, "x": 0.48, "y": 0.75 }, "kind": "metric", "text": "130 countries in which we operate", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "58a2debf-5489-40cc-b906-95dc922f0011", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.25, "x": 0.68, "y": 0.05 }, "kind": "title", "text": "Culture case study: our response to the COVID-19 pandemic", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "03c888c4-7792-441e-b072-a6b292957a8b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.32, "y": 0.05 }, "kind": "title", "text": "Our people and values", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4427298a-5380-4913-a6d5-b1ef743bad9f", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.25, "x": 0.05, "y": 0.15 }, "kind": "title", "text": "Entrepreneurial culture, focused on helping the world", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:12.847+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5ea5777-5706-4167-a584-f12a42a891c0", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "71ac725e-9090-45c9-99ff-05732e5084fb", "evidence": "list/bullet: We follow the science; We put patients first; We play to win; We do the right thing; We are entrepreneurial", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.182648+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 4, "name": "Key Messages", "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 5, "type": "analysis", "title": "The slide uses bar charts to compare historical annual performance against 9M 2022 results.", "function": "analyze_data", "rawType": "kpi_overview", "block": null, "metadata": { "slideType": "kpi_overview", "slideTypeCanon": { "name": "KPI overview (contrarian)", "slug": "kpi_overview", "status": "active", "canonId": "019de52d-11d5-7328-b1d1-5368a03e7796", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "dense", "densityScore": 74, "componentCount": 9, "textChars": 304, "nDataPoints": 15, "notes": "The slide uses bar charts to compare historical annual performance against 9M 2022 results.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.781+00", "seconds": 4.092, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/5", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-5", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.27, "x": 0.06, "y": 0.248 }, "kind": "chart", "text": "Total Revenue", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "11e9fe8f-b799-4f41-9851-ac075234f104", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.27, "x": 0.67, "y": 0.248 }, "kind": "chart", "text": "Net Cash Flow From Operating Activities", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e8eb9b6a-8bc0-4a53-96f7-21930ee0cba5", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.27, "x": 0.36, "y": 0.248 }, "kind": "chart", "text": "Core EPS", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f59b0980-814b-4a98-b4cd-73537c61f2af", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.15, "x": 0.42, "y": 0.68 }, "kind": "metric", "text": "+52%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1be1bab5-f604-4a85-bea1-ac278dc904a4", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.15, "x": 0.12, "y": 0.68 }, "kind": "metric", "text": "+37%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9e75d85f-7ada-4f94-8eab-120ddf6865f4", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.15, "x": 0.73, "y": 0.68 }, "kind": "metric", "text": "+16%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e4da3be9-d185-4c74-9246-b51530276c53", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.4, "x": 0.03, "y": 0.97 }, "kind": "source-note", "text": "1. Growth rates for Total Revenue and Core EPS are at constant exchange rate. EPS = earnings per share.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e5490969-5106-4092-857c-5904f4dfa169", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.94, "x": 0.03, "y": 0.13 }, "kind": "title", "text": "Double digit growth in Oncology, BioPharmaceuticals and Rare Disease driving earnings growth and cash generation", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cabe7ce3-bfbf-4189-a9f4-b05c06ef0a0f", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.27, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Strong financials", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.781+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c4c0271-5539-46cc-b5f0-a3fee3df2d28", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 4, "name": "Key Messages", "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 5, "name": "KPI Overview", "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 6, "type": "setup", "title": "Uses a 2x2 grid layout to categorize capital allocation strategies.", "function": "present_framework", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "dense", "densityScore": 73, "componentCount": 7, "textChars": 425, "nDataPoints": 8, "notes": "Uses a 2x2 grid layout to categorize capital allocation strategies.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:31.102+00", "seconds": 21.258, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/6", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-6", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.2, "w": 0.2, "x": 0.7, "y": 0.27 }, "kind": "chart", "text": "R&D investment split", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Pie chart", "slug": "pie", "status": "active", "canonId": "019de52c-ffdb-71bb-a800-5c5ab9f1c373", "version": 1, "description": null }, "framework": null }, "subkind": "pie", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "59f3fdb6-fe6b-46a3-adf2-3410d6a71852", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.45, "x": 0.05, "y": 0.65 }, "kind": "image", "text": "Acquisitions, Collaborations, and In-licensing partners", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b3e3665e-b9e4-40cc-a1af-fafd82fef0ec", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.4, "x": 0.05, "y": 0.3 }, "kind": "list", "text": "S&P Global and Moody's credit ratings", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e496b4dc-cce9-4fd9-a8dd-74b71efa4010", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.4, "x": 0.55, "y": 0.7 }, "kind": "paragraph", "text": "Progressive dividend policy", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "16b6e54e-c56d-416e-a9f8-ca399cc10eb0", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.9, "x": 0.03, "y": 0.95 }, "kind": "source-note", "text": "1. Core R&D Expense as a percentage of Total Revenue was 21.5% in 9M 2022. 2. Progressive dividend policy defined as dividend per share either stable or increasing in US dollar terms.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "14b2a056-ba05-4dec-94c8-1b8fef403de1", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.8, "x": 0.03, "y": 0.13 }, "kind": "title", "text": "Effective deployment of capital to ensure opportunities for further growth", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "784aa3c2-1b38-4a51-b0a7-31afcab73439", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Capital allocation priorities", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a8dc4ac7-83b3-4ee4-8ce8-025e8a9e4458", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "351bfb55-10a6-410d-831c-09608c7c5e9d", "evidence": "list/bullet: S&P Global and Moody's credit ratings", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.312563+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [ { "matchId": "9e7a276d-2dca-466d-b78d-cfa8c2e13419", "evidence": "The slide explicitly categorizes capital into four distinct strategic buckets (ratings, R&D, BD, dividends).", "framework": null, "confidence": 0.95, "extraction": { "at": "2026-05-02 12:14:31.102+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "capital-allocation-framework" } ], "arcBeats": [ { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 4, "name": "Key Messages", "beatId": "e228d2f7-fd43-46a1-9949-226262cb4c09", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital.", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 5, "name": "KPI Overview", "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 7, "type": "setup", "title": "The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.", "function": "present_framework", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 6, "textChars": 709, "nDataPoints": 0, "notes": "The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.", "elementsJson": null, "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.452+00", "seconds": 3.526, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/7", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-7", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.06, "w": 0.82, "x": 0.14, "y": 0.82 }, "kind": "callout", "text": "Underpinned by advancements in Data, AI and Digital Health", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5655eaa9-65d8-4bdf-b5ca-a9d38c197f55", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.75, "x": 0.18, "y": 0.42 }, "kind": "list", "text": "Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "253c2493-6c2b-4073-89de-ba27947154ef", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.25, "x": 0.18, "y": 0.25 }, "kind": "paragraph", "text": "'Growth Through Innovation' investing in four areas to create the greatest and swiftest impact on disease", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5e2ab40c-46f3-41ec-bea3-aa1f4a8b0183", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.85, "x": 0.03, "y": 0.95 }, "kind": "source-note", "text": "PROTACS = proteolysis targeting chimeras; ADCs = antibody-drug conjugates; CAR-T = chimeric antigen receptor (CAR) T-cell therapy; Treg = regulatory T-cell; siRNA = small interfering ribonucleic acid; mRNA = modified ribonucleic acid; DNA = deoxyribonucleic acid; AI = artificial intelligence.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "77abe851-2132-4868-a593-b0ab3532fd2c", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.03, "y": 0.13 }, "kind": "title", "text": "Extensive R&D investment in cutting-edge platforms and technology", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "700de6c8-0bcb-4731-9a22-14ad9539fe7d", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.45, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Strengthening scientific leadership", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5f0eb449-4daf-4def-83f3-4eaf841074ee", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a877eebb-4f9c-42e1-b4d4-6de563c23de5", "evidence": "list/bullet: Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.399364+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [ { "matchId": "588de2af-e79a-42f1-862b-7e5563375980", "evidence": "Explicitly stated as the strategic framework for R&D investment.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:14:13.452+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "Growth Through Innovation" } ], "arcBeats": [ { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 5, "name": "KPI Overview", "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 8, "type": "setup", "title": "The slide uses a matrix-like structure to compare past performance (9M 2022) with future focus (2023).", "function": "summarize", "rawType": "kpi_overview", "block": null, "metadata": { "slideType": "kpi_overview", "slideTypeCanon": { "name": "KPI overview (contrarian)", "slug": "kpi_overview", "status": "active", "canonId": "019de52d-11d5-7328-b1d1-5368a03e7796", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 46, "componentCount": 3, "textChars": 685, "nDataPoints": 4, "notes": "The slide uses a matrix-like structure to compare past performance (9M 2022) with future focus (2023).", "elementsJson": null, "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:14.449+00", "seconds": 4.492, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/8", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-8", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.05, "w": 0.85, "x": 0.03, "y": 0.93 }, "kind": "source-note", "text": "*Proforma growth. 1. Ultomiris NMOSD regulatory decision anticipated in H1 2023 in US and EU. GI = gastrointestinal; CLL = chronic lymphocytic leukaemia; SGLT2i = sodium-glucose co-transporter-2 inhibitor; aHUS = atypical haemolytic uraemic syndrome; PNH = paroxysmal nocturnal haemoglobinuria; gMG = generalised myasthenia gravis; NMOSD = neuromyelitis optica spectrum disorder. Collaboration partners: Merck (Lynparza), Daiichi Sankyo (Enhertu), Sanofi (Beyfortus), Amgen (Tezspire), Avillion (PT027).", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.449+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f716f14c-8427-4208-9ed1-680b7f92b15a", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.95, "x": 0.03, "y": 0.25 }, "kind": "table", "text": "Matrix comparing 9M 2022 performance and 2023 focus across three therapy areas.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.449+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7d946748-978a-43dc-9116-5d6cd552bd72", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.65, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Continuing momentum in commercial execution across all therapy areas, into new diseases and geographies", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.449+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c87772f0-7a26-4b4f-8aa4-4f1ab2080974", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "3aa95fc4-12a6-4507-aed4-2c529320ade3", "evidence": "table/data: Matrix comparing 9M 2022 performance and 2023 focus across three therapy areas.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.486165+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 5, "name": "KPI Overview", "beatId": "48ed926e-7814-46ee-a629-10f94cf90551", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Financials and KPIs are presented to show strong performance and momentum.", "position": 2, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "setup", "title": "The slide highlights the strategic fit of the CinCor acquisition (baxdrostat) into the existing CVRM pipeline.", "function": "present_solution", "rawType": "thesis_headline", "block": null, "metadata": { "slideType": "thesis_headline", "slideTypeCanon": { "name": "Thesis headline", "slug": "thesis_headline", "status": "active", "canonId": "019de52d-073a-70cb-b9f6-772a597bb5af", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 80, "componentCount": 7, "textChars": 737, "nDataPoints": 1, "notes": "The slide highlights the strategic fit of the CinCor acquisition (baxdrostat) into the existing CVRM pipeline.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:18.666+00", "seconds": 8.288, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/9", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-9", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.58, "x": 0.03, "y": 0.22 }, "kind": "image", "text": "Pipeline mapping of CVRM diseases to drugs", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Infographic", "slug": "infographic", "status": "active", "canonId": "019de52c-fe26-750c-9d7d-9f34e21324e8", "version": 1, "description": null }, "framework": null }, "subkind": "infographic", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d7f9f874-d4ff-4a81-a9ce-3f1c80537d2f", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.15, "x": 0.77, "y": 0.45 }, "kind": "metric", "text": "7 million", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8d979807-4637-4a6c-af38-0350475f2054", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.35, "x": 0.62, "y": 0.22 }, "kind": "paragraph", "text": "The clinical burden of treatment resistant hypertension. Hypertension, a silent killer: systolic blood pressure above 130 / 80 mm Hg. 7 million patients in the US are on three or more anti-hypertensive medicines and are still not at BP goal - treatment resistant.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "196f8846-7157-495a-8247-cc8c4cdf8a85", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.35, "x": 0.62, "y": 0.7 }, "kind": "paragraph", "text": "Current standard of care: ASIs and MRAs (spironolactone) target the aldosterone pathway to lower BP. MRAs -> undesirable androgenic side effects e.g., gynecomastia", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bfab6a12-8efe-4762-906a-302eeb3db299", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.6, "x": 0.03, "y": 0.96 }, "kind": "source-note", "text": "BP = blood pressure; ASIs = aldosterone synthase inhibitors; MRAs = mineralocorticoid receptor antagonists. Collaboration partner: Ionis (eplontersen).", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "26f769dd-4553-4719-958e-fc7960dc1c29", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.03, "y": 0.13 }, "kind": "title", "text": "AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2f5f24c3-ee42-4494-aa6e-32ad89449af2", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "AstraZeneca positioned to lead in CVRM", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:18.666+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9770346b-ef3a-42d1-95a8-a8f61f138e10", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 9, "name": "Thesis Headline", "beatId": "d24e6f2d-ed7f-45f3-8426-4526ac01fda7", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 10, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null }, "matchId": "f577db34-3711-4966-ab1d-a155e7015552", "evidence": "The presentation highlights the strategic rationale for the acquisition at this time.", "position": 1, "objective": "To justify the timing of the acquisition of CinCor Pharma", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:29:13.514063+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "setup", "title": "Includes clinical trial data visualization and deal structure details.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 84, "componentCount": 7, "textChars": 1182, "nDataPoints": 4, "notes": "Includes clinical trial data visualization and deal structure details.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.741+00", "seconds": 3.262, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/10", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-10", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.25, "w": 0.25, "x": 0.14, "y": 0.55 }, "kind": "chart", "text": "Change in Systolic Blood Pressure over Time", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3d4bdc13-3695-45a8-863c-de6fcd9a80b1", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.45, "x": 0.5, "y": 0.22 }, "kind": "list", "text": "Hypertension: high-risk factor for stroke, CAD, heart attack and CKD; current treatment options limited. Baxdrostat is a potential leading next-generation ASI. Strong strategic fit to build leading cardiorenal portfolio.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "210fb97f-c99a-457a-945d-ca3ecf548493", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.42, "x": 0.05, "y": 0.22 }, "kind": "paragraph", "text": "Baxdrostat (CIN-107) โ€“ a highly selective, aldosterone synthase inhibitor (ASI). Baxdrostat is highly selective for aldosterone synthase and spares the cortisol pathway. BrighTN Phase II trial: Baxdrostat significantly reduced systolic BP.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5a24d6eb-1010-4c49-b5e9-e0c670e5810a", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.02, "y": 0.95 }, "kind": "source-note", "text": "CCB = calcium channel blockers; BBs = beta blockers; ACE = angiotensin-converting enzyme; AE = adverse events; ARBs = angiotensin receptor blockers; ASI = aldosterone synthase inhibitors; MRAs = mineralocorticoid receptor antagonists; CAD = coronary arterial disease; CKD = chronic kidney disease; BP = blood pressure; trHTN = treatment-resistant hypertension.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fc29dafb-4474-46da-842f-04534195cdf9", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.45, "x": 0.5, "y": 0.58 }, "kind": "table", "text": "Deal terms: $26 per share in cash at deal closing ($1.3bn); AstraZeneca will acquire CinCorโ€™s cash and marketable securities (~$0.5bn); A non-tradable contingent value right of $10 per share.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9ba2b959-3d9b-4b58-9de6-9f6e4f4eb887", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.7, "x": 0.03, "y": 0.12 }, "kind": "title", "text": "A potential best-in-class ASI for treatment resistant hypertension", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6c223ebe-184c-4d3e-8fee-82f132ec2a39", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.9, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "Baxdrostat: addresses a large unmet need in cardiorenal disease", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.741+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f725cbd8-28d3-4976-8222-3782ceb0b47f", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "148e3c75-ec2b-4cf6-8ba9-fc0b7645c2a8", "evidence": "type: executive_summary", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:16:56.618016+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 10, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 9, "name": "Thesis Headline", "beatId": "d24e6f2d-ed7f-45f3-8426-4526ac01fda7", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 10, "from": 9, "loop": { "name": "15_why_now", "slug": "15-why-now", "status": "active", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "canonId": "019dd956-6c00-70cd-bd42-6bacc4af726f", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "description": "Create temporal urgency by proving that the window of opportunity is opening or closing", "familyLabel": null }, "matchId": "f577db34-3711-4966-ab1d-a155e7015552", "evidence": "The presentation highlights the strategic rationale for the acquisition at this time.", "position": 1, "objective": "To justify the timing of the acquisition of CinCor Pharma", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:29:13.514063+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "resolution", "title": "The slide uses a list-based layout to categorize clinical milestones.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "dense", "densityScore": 73, "componentCount": 6, "textChars": 1065, "nDataPoints": 0, "notes": "The slide uses a list-based layout to categorize clinical milestones.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:14.364+00", "seconds": 3.66, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/11", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-11", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.9, "w": 0.25, "x": 0.02, "y": 0.05 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "589f1c00-598a-40e1-9036-047bbc19844f", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.4, "x": 0.28, "y": 0.42 }, "kind": "list", "text": "Regulatory approvals in major markets, including:", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c7cfc5b-f715-427d-bbae-1ff8e511bb11", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.28, "y": 0.22 }, "kind": "list", "text": "Positive Phase III data readouts, selected", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f7282669-a0c3-47f9-9717-1cc443ed8b2d", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.96, "x": 0.02, "y": 0.92 }, "kind": "source-note", "text": "HER2-low = human epidermal growth factor receptor 2-low; NMOSD = neuromyelitis optica spectrum disorder; HFpEF = heart failure with preserved ejection fraction; ATTRv-PN = hereditary transthyretin-mediated amyloid polyneuropathy; PNH = paroxysmal nocturnal haemoglobinuria; EVH = extravascular haemolysis; gMG = generalised myasthenia gravis; HER2-positive = human epidermal growth factor receptor 2-positive; EGFRm = epidermal growth factor receptor mutated; RSV = respiratory syncytial virus; HRD-positive = homologous recombination deficiency-positive; NF1 = neurofibromatosis, type 1; PN = plexiform neurofibromas; aHUS = atypical haemolytic uraemic syndrome; CRPC = castrate-resistant cancer; chronic lymphocytic leukaemia; CLL = chronic lymphocytic leukaemia. Collaboration partners: Merck (Lynparza, Koselugo), Daiichi Sankyo (Enhertu), Sanofi (Beyfortus), Amgen (Tezspire).", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "447c358b-4ef1-44b8-a7a6-0c0121d1e924", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.28, "y": 0.13 }, "kind": "title", "text": "Exceptional delivery of best-in-industry pipeline", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dca6eb87-b654-4365-a641-da84d6f8038b", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.6, "x": 0.28, "y": 0.05 }, "kind": "title", "text": "2022: An incredible year of clinical success", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.364+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5afad5fa-cdb0-4b60-a51a-e29937aca18f", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "1928505f-be27-4654-b57a-8fb832759f37", "evidence": "list/bullet: Regulatory approvals in major markets, including:", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:16:56.704313+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Executive Summary", "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "Summarizing the company's position and strategy for growth.", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 12, "type": "resolution", "title": "The slide uses a combination of a timeline (H1/H2 2023) and a list for the pipeline. It includes a comprehensive legend for abbreviations at the bottom.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "balanced", "densityScore": 42, "componentCount": 5, "textChars": 231, "nDataPoints": 0, "notes": "The slide uses a combination of a timeline (H1/H2 2023) and a list for the pipeline. It includes a comprehensive legend for abbreviations at the bottom.", "elementsJson": null, "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.705+00", "seconds": 2.82, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/12", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-12", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.62, "x": 0.03, "y": 0.15 }, "kind": "diagram", "text": "H1 2023 and H2 2023 newsflow", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf", "version": 1, "description": null }, "framework": null }, "subkind": "timeline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f2eecf2b-ba07-4542-b7d6-b51de4708585", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.52, "x": 0.13, "y": 0.22 }, "kind": "list", "text": "Regulatory decisions and Phase III data readouts categorized by H1/H2 2023", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dd3dac13-cbd6-4fe5-8dc2-b4e1d2484230", "parentComponentId": null }, { "bbox": { "h": 0.75, "w": 0.18, "x": 0.78, "y": 0.15 }, "kind": "list", "text": "Next wave early pipeline list", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f3b7c570-316d-44e7-a991-4d3826f9b2e4", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.95, "x": 0.03, "y": 0.91 }, "kind": "source-note", "text": "Abbreviations and collaboration partners legend", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bf2d0b5a-c731-42e2-bf08-ce2b7d68c034", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.55, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "Key upcoming newsflow and selected next wave pipeline", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3feed34d-3e38-4735-8361-2868e67b613d", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "cb2c11da-cabc-4275-9887-9fc9081c2dd8", "evidence": "Chronological presentation of H1 and H2 2023 events", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:14:13.705+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "frameworkName": "timeline" } ], "arcBeats": [ { "to": 13, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 12, "name": "Roadmap", "beatId": "c2902914-1df6-44f4-9a90-1f972465d662", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory.", "position": 5, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 13, "type": "setup", "title": "The slide uses a combination of a horizontal bar chart for product durability and a vertical bar chart for revenue growth projections.", "function": "summarize", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 37, "componentCount": 4, "textChars": 320, "nDataPoints": 0, "notes": "The slide uses a combination of a horizontal bar chart for product durability and a vertical bar chart for revenue growth projections.", "elementsJson": null, "confidence": 0.95, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.337+00", "seconds": 2.369, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/13", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-13", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.28, "x": 0.05, "y": 0.235 }, "kind": "chart", "text": "Optimised LoE profile", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.337+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c70d8e05-88bc-494c-9619-88516ef8c02a", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.6, "x": 0.35, "y": 0.235 }, "kind": "chart", "text": "Growth from robust portfolio and an innovative pipeline", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.337+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "29f9a89e-8483-4534-8c39-64d7e162068d", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.7, "x": 0.03, "y": 0.95 }, "kind": "source-note", "text": "1. Constant Exchange Rates. 2. CAGR = compound annual growth rate. Double-digit CAGR of non-COVID-19 Total Revenue from 2021 (Alexion proforma) to 2025, assuming Constant Exchange Rates.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.337+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1b47a11f-b4f5-4433-a45b-ac317a1d2d24", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "AstraZeneca: positioned to deliver industry-leading growth", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.337+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "20b86a15-a82d-4878-aa21-e9e83429338d", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "aa882962-b243-4dca-b0bb-631b64cadb39", "evidence": "chart/bar-vertical: Growth from robust portfolio and an innovative pipeline", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:17:38.095808+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 13, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 12, "name": "Roadmap", "beatId": "c2902914-1df6-44f4-9a90-1f972465d662", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory.", "position": 5, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 14, "type": "setup", "title": "The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.", "function": "present_solution", "rawType": "thesis_headline", "block": null, "metadata": { "slideType": "thesis_headline", "slideTypeCanon": { "name": "Thesis headline", "slug": "thesis_headline", "status": "active", "canonId": "019de52d-073a-70cb-b9f6-772a597bb5af", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 68, "componentCount": 6, "textChars": 640, "nDataPoints": 0, "notes": "The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:14.938+00", "seconds": 3.823, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/14", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-14", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.3, "w": 0.35, "x": 0.6, "y": 0.35 }, "kind": "callout", "text": "Committed to delivering Low double-digit revenue CAGR through 2025 AND industry-leading growth 2025+", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "71919369-1611-46a5-b0cb-9e026c1c1578", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.13, "x": 0.03, "y": 0.25 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "374e72c4-c3ac-41ad-b80d-51bdd9e295c5", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.35, "x": 0.16, "y": 0.26 }, "kind": "list", "text": "1. Industry-leading execution: Strong track-record across key therapy areas. 2. Late-stage pipeline success: Robust breadth and depth of Phase II and Phase III programmes including several high potential medicines. 3. Investment in early-stage: Advancing key assets with blockbuster-potential and investing in new platforms and technology to unlock the next waves of growth", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Numbered list", "slug": "numbered", "status": "active", "canonId": "019de52c-fcc0-7718-a284-a4250c805df2", "version": 1, "description": null }, "framework": null }, "subkind": "numbered", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1df3bd60-10fe-41a6-9c87-4266ec8854d3", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.2, "x": 0.03, "y": 0.97 }, "kind": "source-note", "text": "CAGR = compound annual growth rate.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "287eb0e7-39e2-4381-aa0d-aaacb2a2ba70", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.6, "x": 0.03, "y": 0.13 }, "kind": "title", "text": "Multiple organic levers drive momentum and sustain attractive growth profile", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "98b34017-22e8-437b-ba0e-87f3b4093db4", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.55, "x": 0.03, "y": 0.06 }, "kind": "title", "text": "AstraZeneca: a sustainable, long-term growth opportunity", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c431695-d7d9-401c-bef6-1dc60bc06e71", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "fdc5cc13-0742-4b7e-b56b-cd92b28c51ca", "evidence": "Numbered list of strategic pillars", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:14:14.938+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "frameworkName": "list-presentation" } ], "arcBeats": [], "loops": [ { "to": 14, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "88983257-4d74-4000-ae54-8166a2051abc", "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.", "position": 0, "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:29:13.479291+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 15, "type": "setup", "function": "state_next_steps", "rawType": "closing_ask", "block": null, "metadata": { "slideType": "closing_ask", "slideTypeCanon": { "name": "Closing ask", "slug": "closing_ask", "status": "active", "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c", "version": 1, "description": null }, "function": "state_next_steps", "functionCanon": { "name": "State next steps", "slug": "state_next_steps", "status": "active", "canonId": "019de52d-14ca-70ac-b534-971f458cdf29", "version": 1, "description": null }, "density": "sparse", "densityScore": 3, "componentCount": 2, "textChars": 24, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:14.094+00", "seconds": 2.963, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/15", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-15", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 1, "w": 0.61, "x": 0.39, "y": 0 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.094+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0aef1a21-e269-40d0-81fc-74a112ee1318", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.25, "x": 0.108, "y": 0.415 }, "kind": "title", "text": "Closing comments and Q&A", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.094+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2bf0f41a-f3f1-4746-adae-3eb88019d3be", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 15, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 15, "name": "Closing Ask", "beatId": "d25d54ad-e329-4cda-a857-30b5fce1a06b", "matchId": "f8bba84f-9f61-4110-bf71-5b7ad42c0120", "beatType": null, "evidence": "The presentation concludes with a call for Q&A, engaging investors directly.", "position": 6, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 16, "type": "setup", "function": "other", "rawType": "team_bio", "block": null, "metadata": { "slideType": "team_bio", "slideTypeCanon": { "name": "Team bio", "slug": "team_bio", "status": "active", "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 82, "componentCount": 15, "textChars": 618, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:15.512+00", "seconds": 4.138, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/16", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-16", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.08, "w": 0.08, "x": 0.32, "y": 0.135 }, "kind": "image", "text": "Andy Barnett", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "12abd564-c83c-4c45-a433-6e3d0ce66e02", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.655, "y": 0.535 }, "kind": "image", "text": "Lauren Swales", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2aef3372-9378-4340-8191-ca07c1bfe863", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.32, "y": 0.335 }, "kind": "image", "text": "Morgan Sanford", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2e52fe42-22b7-4ccc-b0b1-47a4a55f7f16", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.655, "y": 0.335 }, "kind": "image", "text": "Christer Gruvris", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "373503df-97fc-4cd0-88c4-97b466f255d7", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.32, "y": 0.535 }, "kind": "image", "text": "Philip Sparks", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37a92782-f85d-42b5-b0af-09ce8d5fccce", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.655, "y": 0.135 }, "kind": "image", "text": "Josie Afolabi", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6273dbc3-34d1-4c11-90a2-c9a25818f378", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.08, "x": 0.32, "y": 0.735 }, "kind": "image", "text": "Rachel Korolyshun", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9344e531-5401-41fe-9239-0d925af30080", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.425, "y": 0.76 }, "kind": "paragraph", "text": "Rachel Korolyshun, Rare Disease, ESG, rachel.korolyshun@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "266edcb9-b5f2-4176-a89f-0fd3bba64fdd", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.425, "y": 0.56 }, "kind": "paragraph", "text": "Philip Sparks, BioPharma (R&I, V&I), Other medicines, philip.sparks1@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "353e3862-1009-4b44-81f3-301bb7383190", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.76, "y": 0.56 }, "kind": "paragraph", "text": "Lauren Swales, Rare Disease, ESG, lauren.swales@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3d391382-3dcb-492e-9a20-8d74c584ecba", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.425, "y": 0.16 }, "kind": "paragraph", "text": "Andy Barnett, Head of Investor Relations, andrew.barnett@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5d1d6da4-28d4-42f7-add1-53121bc55836", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.76, "y": 0.36 }, "kind": "paragraph", "text": "Christer Gruvris, BioPhamaceuticals (CVRM), Finance and Fixed Income, christer.gruvris@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "73271596-e49f-46ab-b5d5-5ee9f10023ec", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.76, "y": 0.16 }, "kind": "paragraph", "text": "Josie Afolabi, Oncology, josie.afolabi@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a1bac590-4cc2-4ada-8b4a-35a028682f8d", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.2, "x": 0.425, "y": 0.36 }, "kind": "paragraph", "text": "Morgan Sanford, Oncology, morgan.sanford@astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ed9878a4-5f92-474b-9dd7-ba52c50c54bc", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.2, "x": 0.03, "y": 0.425 }, "kind": "title", "text": "Investor Relations", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:15.512+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8e6afe10-a899-4aa6-9825-dea7a2e79590", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 17, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "dense", "densityScore": 56, "componentCount": 4, "textChars": 2419, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:14.883+00", "seconds": 3.23, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/17", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-17", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.52 }, "kind": "disclaimer", "text": "Investors and security holders may obtain a free copy of the Offer to Purchase, the related Letter of Transmittal, certain other tender offer documents and the Solicitation/Recommendation Statement (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the information agent for the tender offer, which will be named in the tender offer statement. In addition, CinCor files annual, quarterly and current reports and other information, and AstraZeneca files annual reports and other information with the SEC, which are available to the public from commercial document-retrieval services and at the SEC's website at www.sec.gov. Copies of the documents filed with the SEC by AstraZeneca may be obtained at no charge on AstraZeneca's internet website at www.astrazeneca.com/investors. Copies of the documents filed with the SEC by CinCor may be obtained at no charge under the \"Investors\" section of CinCor's internet website at www.cincor.com.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.883+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6f64f423-2ea9-4f38-b07b-6631c2e2638f", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.23 }, "kind": "disclaimer", "text": "The tender offer described in this presentation has not yet commenced. This presentation is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of CinCor or any other securities, nor is it a substitute for the tender offer materials described herein. At the time the planned tender offer is commenced, a tender offer statement on Schedule TO, including an offer to purchase, a letter of transmittal and related documents, will be filed by AstraZeneca PLC (AstraZeneca), AstraZeneca Finance and Holdings Inc. and Cinnamon Acquisition, Inc., a wholly-owned indirect subsidiary of AstraZeneca, with the Securities and Exchange Commission (the SEC), and a solicitation/recommendation statement on Schedule 14D-9 will be filed by CinCor with the SEC.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.883+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "86466f55-1297-45f7-8efd-fc5032213aba", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.9, "x": 0.05, "y": 0.39 }, "kind": "disclaimer", "text": "INVESTORS AND SECURITY HOLDERS ARE URGED TO CAREFULLY READ BOTH THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 REGARDING THE OFFER, AS THEY MAY BE AMENDED FROM TIME TO TIME , WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SECURITIES.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.883+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cad80aa2-3ca4-4d0f-b0ba-4dbf62e8ffe2", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.45, "x": 0.05, "y": 0.06 }, "kind": "title", "text": "Important information about the tender offer", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:14.883+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fb4e0e97-6347-4600-8957-791bed6d6a79", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 18, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "balanced", "densityScore": 31, "componentCount": 2, "textChars": 510, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:14:13.555+00", "seconds": 1.891, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de074-2763-7087-8fbd-df19b6e58266/18", "deck": "/decks/019de074-2763-7087-8fbd-df19b6e58266", "deckAnchor": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-18", "deckJson": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json" }, "components": [ { "bbox": { "h": 0.08, "w": 0.78, "x": 0.043, "y": 0.76 }, "kind": "disclaimer", "text": "This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK, T: +44(0)203 749 5000, www.astrazeneca.com", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.555+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cb248c65-390a-4372-9de9-faca95af30f6", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.15, "x": 0.043, "y": 0.72 }, "kind": "title", "text": "Confidentiality Notice", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:14:13.555+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e56e1698-1deb-4062-bda9-0984e2c40ace", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 1, "to": 3, "label": "Why", "description": "The presentation begins with AstraZeneca's mission and strategic focus (Science-led, patient-centered)." }, { "from": 4, "to": 6, "label": "Key Messages", "description": "The deck then elaborates on key messages including entrepreneurial culture and effective deployment of capital." }, { "from": 5, "to": 8, "label": "KPI Overview", "description": "Financials and KPIs are presented to show strong performance and momentum." }, { "from": 9, "to": 10, "label": "Thesis Headline", "description": "A specific strategic action (acquisition) is highlighted to strengthen the pipeline." }, { "from": 3, "to": 11, "label": "Executive Summary", "description": "Summarizing the company's position and strategy for growth." }, { "from": 12, "to": 13, "label": "Roadmap", "description": "The deck outlines key upcoming newsflow and pipeline, showing a clear growth trajectory." }, { "from": 15, "to": 15, "label": "Closing Ask", "description": "The presentation concludes with a call for Q&A, engaging investors directly." } ], "loops": [ { "from": 3, "to": 14, "label": "Golden Circle", "description": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it" }, { "from": 9, "to": 10, "label": "Why Now", "description": "To justify the timing of the acquisition of CinCor Pharma" } ] }